Gini Fleming to Glucuronosyltransferase
This is a "connection" page, showing publications Gini Fleming has written about Glucuronosyltransferase.
Connection Strength
0.069
-
UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Pharmacogenomics J. 2002; 2(1):43-7.
Score: 0.045
-
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751. Pharmacogenet Genomics. 2013 Jul; 23(7):374-81.
Score: 0.025